{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:09:43Z","timestamp":1791180583484,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>The osteocyte product sclerostin is emerging as an important paracrine regulator of bone mass. It has recently been shown that osteocyte production of receptor activator of NF-\u03baB ligand (RANKL) is important in osteoclastic bone resorption, and we reported that exogenous treatment of osteocytes with sclerostin can increase RANKL-mediated osteoclast activity. There is good evidence that osteocytes can themselves liberate mineral from bone in a process known as osteocytic osteolysis. In the current study, we investigated sclerostin-stimulated mineral dissolution by human primary osteocyte-like cells (hOCy) and mouse MLO-Y4 cells. We found that sclerostin upregulated osteocyte expression of carbonic anhydrase 2 (CA2\/Car2), cathepsin K (CTSK\/Ctsk), and tartrate-resistant acid phosphatase (ACP5\/Acp5). Because acidification of the extracellular matrix is a critical step in the release of mineral from bone, we further examined the regulation by sclerostin of CA2. Sclerostin stimulated CA2 mRNA and protein expression in hOCy and in MLO-Y4 cells. Sclerostin induced a decrease in intracellular pH (pHi) in both cell types as well as a decrease in extracellular pH (pHo) and the release of calcium ions from mineralized substrate. These effects were reversed in the co-presence of the carbonic anhydrase inhibitor, acetozolamide. Car2-siRNA knockdown in MLO-Y4 cells significantly inhibited the ability of sclerostin to both reduce the pHo and release calcium from a mineralized substrate. Knockdown in MLO-Y4 cells of each of the putative sclerostin receptors, Lrp4, Lrp5 and Lrp6, using siRNA, inhibited the sclerostin induction of Car2, Catk and Acp5 mRNA, as well as pHo and calcium release. Consistent with this activity of sclerostin resulting in osteocytic osteolysis, human trabecular bone samples treated ex vivo with recombinant human sclerostin for 7 days exhibited an increased osteocyte lacunar area, an effect that was reversed by the co-addition of acetozolamide. These findings suggest a new role for sclerostin in the regulation of perilacunar mineral by osteocytes. \u00a9 2013 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2003","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T11:31:49Z","timestamp":1370431909000},"page":"2436-2448","source":"Crossref","is-referenced-by-count":147,"title":["Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2"],"prefix":"10.1093","volume":"28","author":[{"given":"Masakazu","family":"Kogawa","sequence":"first","affiliation":[{"name":"Bone Cell Biology Group, Centre for Orthopaedic & Trauma ResearchDiscipline of Orthopaedics and Trauma, University of AdelaideAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiri R","family":"Wijenayaka","sequence":"additional","affiliation":[{"name":"Bone Cell Biology Group, Centre for Orthopaedic & Trauma ResearchDiscipline of Orthopaedics and Trauma, University of AdelaideAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee T","family":"Ormsby","sequence":"additional","affiliation":[{"name":"Bone Cell Biology Group, Centre for Orthopaedic & Trauma ResearchDiscipline of Orthopaedics and Trauma, University of AdelaideAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gethin P","family":"Thomas","sequence":"additional","affiliation":[{"name":"Diamantina InstituteUniversity of QueenslandWoolloongabbaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H","family":"Anderson","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical SciencesUniversity of South Australia and Chemical PathologySA PathologyAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda F","family":"Bonewald","sequence":"additional","affiliation":[{"name":"Department of Oral BiologyUniversity of Missouri\u2013Kansas City School of DentistryKansas CityMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Findlay","sequence":"additional","affiliation":[{"name":"Bone Cell Biology Group, Centre for Orthopaedic & Trauma ResearchDiscipline of Orthopaedics and Trauma, University of AdelaideAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J","family":"Atkins","sequence":"additional","affiliation":[{"name":"Bone Cell Biology Group, Centre for Orthopaedic & Trauma ResearchDiscipline of Orthopaedics and Trauma, University of AdelaideAdelaideAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"key":"2024020318324958000_jbmr2003-bib-0001","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"Faseb J."},{"key":"2024020318324958000_jbmr2003-bib-0002","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"Embo J."},{"key":"2024020318324958000_jbmr2003-bib-0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Human Mol Genet."},{"key":"2024020318324958000_jbmr2003-bib-0004","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet."},{"key":"2024020318324958000_jbmr2003-bib-0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet."},{"key":"2024020318324958000_jbmr2003-bib-0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet."},{"key":"2024020318324958000_jbmr2003-bib-0007","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0008","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/jbmr.081235","article-title":"Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone","volume":"24","author":"Williams","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0010","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS ONE."},{"key":"2024020318324958000_jbmr2003-bib-0011","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in LRP4 impair sclerostin-facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0012","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","article-title":"Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism","volume":"26","author":"Atkins","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0013","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One."},{"key":"2024020318324958000_jbmr2003-bib-0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med."},{"key":"2024020318324958000_jbmr2003-bib-0015","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med."},{"key":"2024020318324958000_jbmr2003-bib-0016","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00198-012-1915-z","article-title":"Osteocyte regulation of bone mineral: a little give and take","volume":"23","author":"Atkins","year":"2012","journal-title":"Osteoporos Int."},{"key":"2024020318324958000_jbmr2003-bib-0017","first-page":"270","article-title":"Effects of hormones on osteocyte function and perilacunar wall structure","volume":"136","author":"Baud","year":"1978","journal-title":"Clin Orthop Relat Res."},{"key":"2024020318324958000_jbmr2003-bib-0018","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0019","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jbmr.1646","article-title":"Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance","volume":"27","author":"Tang","year":"2012","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2008.09.017","article-title":"Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited","volume":"44","author":"Teti","year":"2009","journal-title":"Bone."},{"key":"2024020318324958000_jbmr2003-bib-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02279101","article-title":"Osteocytic osteolysis","volume":"4","author":"Belanger","year":"1969","journal-title":"Calcif Tissue Res."},{"key":"2024020318324958000_jbmr2003-bib-0022","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-1-4684-7758-0_45","article-title":"Effect of PTH on osteocyte ultrastructure","volume":"103","author":"Krempien","year":"1978","journal-title":"Adv Exp Med Biol."},{"key":"2024020318324958000_jbmr2003-bib-0023","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00774-004-0519-x","article-title":"Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered","volume":"22","author":"Tazawa","year":"2004","journal-title":"J Bone Miner Metab."},{"key":"2024020318324958000_jbmr2003-bib-0024","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/pr8005606","article-title":"Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates","volume":"8","author":"Bivi","year":"2009","journal-title":"J Proteome Res."},{"key":"2024020318324958000_jbmr2003-bib-0025","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1359\/jbmr.1997.12.12.2014","article-title":"Establishment of an osteocyte-like cell line, MLO-Y4","volume":"12","author":"Kato","year":"1997","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0026","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.2003.18.6.1088","article-title":"RANKL expression is related to the differentiation state of human osteoblasts","volume":"18","author":"Atkins","year":"2003","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0027","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00198-008-0728-6","article-title":"Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response","volume":"20","author":"Atkins","year":"2009","journal-title":"Osteoporos Int."},{"key":"2024020318324958000_jbmr2003-bib-0028","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.biomaterials.2009.03.035","article-title":"The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles","volume":"30","author":"Atkins","year":"2009","journal-title":"Biomaterials."},{"key":"2024020318324958000_jbmr2003-bib-0029","doi-asserted-by":"crossref","first-page":"C1358","DOI":"10.1152\/ajpcell.00216.2009","article-title":"Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by \u03b3-carboxylation-dependent and -independent mechanisms","volume":"297","author":"Atkins","year":"2009","journal-title":"Am J Physiol Cell Physiol."},{"key":"2024020318324958000_jbmr2003-bib-0030","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","article-title":"Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1alpha,25-dihydroxyvitamin D(3)","volume":"40","author":"Atkins","year":"2007","journal-title":"Bone."},{"key":"2024020318324958000_jbmr2003-bib-0031","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption","volume":"151","author":"Kogawa","year":"2010","journal-title":"Endocrinology."},{"key":"2024020318324958000_jbmr2003-bib-0032","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M408795200","article-title":"Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1","volume":"279","author":"Matsumoto","year":"2004","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0033","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0006-291X(75)80475-X","article-title":"Fluorescein conjugates of cytochrome c as internal pH probes in submitochondrial particles","volume":"65","author":"Thomas","year":"1975","journal-title":"Biochem Biophys Res Comm."},{"key":"2024020318324958000_jbmr2003-bib-0034","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diabetes.51.1.105","article-title":"Intracellular pH plays a critical role in glucose-induced time-dependent potentiation of insulin release in rat islets","volume":"51","author":"Gunawardana","year":"2002","journal-title":"Diabetes."},{"key":"2024020318324958000_jbmr2003-bib-0035","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/bi00578a012","article-title":"Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ","volume":"18","author":"Thomas","year":"1979","journal-title":"Biochemistry."},{"key":"2024020318324958000_jbmr2003-bib-0036","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biomaterials.2003.09.005","article-title":"The proliferation and phenotypic expression of human osteoblasts on tantalum metal","volume":"25","author":"Findlay","year":"2004","journal-title":"Biomaterials."},{"key":"2024020318324958000_jbmr2003-bib-0037","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"key":"2024020318324958000_jbmr2003-bib-0038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/0929867033368493","article-title":"Gene silencing mediated by small interfering RNAs in mammalian cells","volume":"10","author":"Scherr","year":"2003","journal-title":"Curr Med Chem."},{"key":"2024020318324958000_jbmr2003-bib-0039","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bone.2008.12.026","article-title":"The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading","volume":"44","author":"Moustafa","year":"2009","journal-title":"Bone."},{"key":"2024020318324958000_jbmr2003-bib-0041","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00198-011-1656-4","article-title":"Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered","volume":"23","author":"Moustafa","year":"2012","journal-title":"Osteoporos Int."},{"key":"2024020318324958000_jbmr2003-bib-0042","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","article-title":"Structure, function and applications of carbonic anhydrase isozymes","volume":"21","author":"Imtaiyaz Hassan","year":"2013","journal-title":"Bioorg Med Chem."},{"key":"2024020318324958000_jbmr2003-bib-0043","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1242\/dev.025825","article-title":"BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway","volume":"135","author":"Kamiya","year":"2008","journal-title":"Development."},{"key":"2024020318324958000_jbmr2003-bib-0044","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0046","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","article-title":"LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST","volume":"281","author":"Semenov","year":"2006","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0047","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bone.2010.05.032","article-title":"Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats","volume":"47","author":"Tian","year":"2010","journal-title":"Bone."},{"key":"2024020318324958000_jbmr2003-bib-0048","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0009-9120(91)80005-N","article-title":"Evaluation of carbonic anhydrase isozymes in disorders involving osteopetrosis and\/or renal tubular acidosis","volume":"24","author":"Sly","year":"1991","journal-title":"Clin Biochem."},{"key":"2024020318324958000_jbmr2003-bib-0049","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-007-9098-x","article-title":"Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice","volume":"82","author":"Margolis","year":"2008","journal-title":"Calcif Tissue Int."},{"key":"2024020318324958000_jbmr2003-bib-0050","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0051","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.str.2011.07.005","article-title":"Wnt antagonists bind through a short peptide to the first beta-propeller domain of LRP5\/6","volume":"19","author":"Bourhis","year":"2011","journal-title":"Structure."},{"key":"2024020318324958000_jbmr2003-bib-0052","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0053","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0054","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is sltered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif Tissue Int."},{"key":"2024020318324958000_jbmr2003-bib-0055","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.040907","article-title":"Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6","volume":"19","author":"Holmen","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0056","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1073\/pnas.1007428107","article-title":"Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies","volume":"107","author":"Ettenberg","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"2024020318324958000_jbmr2003-bib-0057","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4419-6612-4_34","article-title":"TWEAK and TNF regulation of sclerostin: a novel pathway for the regulation of bone remodelling","volume":"691","author":"Findlay","year":"2011","journal-title":"Adv Exp Med Biol."},{"key":"2024020318324958000_jbmr2003-bib-0058","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1359\/jbmr.090305","article-title":"Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts","volume":"24","author":"Vincent","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0059","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2024020318324958000_jbmr2003-bib-0060","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.1074\/jbc.M306249200","article-title":"Cbfa1\/RUNX2 directs specific expression of the sclerosteosis gene (SOST)","volume":"279","author":"Sevetson","year":"2004","journal-title":"J Biol Chem."},{"key":"2024020318324958000_jbmr2003-bib-0061","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bone.2004.04.019","article-title":"Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone."},{"key":"2024020318324958000_jbmr2003-bib-0062","article-title":"LRP4 is a novel osteoblast and osteocyte expressed specific facilitator of SOST-mediated inhibition of in vitro bone formation","volume":"24","author":"Leupin","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318324958000_jbmr2003-bib-0063","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jbmr.1608","article-title":"Absence of sclerostin adversely affects B-cell survival","volume":"27","author":"Cain","year":"2012","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2003","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/12\/2436\/56562468\/jbmr2003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/12\/2436\/56562468\/jbmr2003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:49:45Z","timestamp":1710341385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/28\/12\/2436-2448\/7598525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,6,5]]},"published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2003","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,12,1]]},"published":{"date-parts":[[2013,6,5]]}}}